Consumer health tool Your.MD lands $30M to expand its market footprint

Consumer health tool Your.MD lands $30M to expand its market footprint

This morning Your.MD, a digital symptom checker and personal health tool Healthily, scored $30 million in Series A funding.
The latest round of funding was driven by Reckitt Benckiser (RB), a consumer health company.
WHAT THEY DO

HIMSS20 Digital
Learn on-demand, earn credit, find products and solutions. Get Started >>

The London-based startup was founded in 2015. Its tool was designed to help patients make decisions about their health, including when to see a doctor and what level of care to seek. Users can go to the platform to check symptoms, take a coronavirus risk assessment, take a self-assessment about the risk for certain conditions like alcohol misuse and ADHD, and take health-related quizzes.
Its app can suggest providers in a user’s geographical area. Users can also log trends and conditions in a digital health journal. 
More recently the company has added a specific coronavirus symptom mapper that was designed to help compare symptoms and help the company map the spread of the disease, in conjunction with Imperial College London.
WHAT IT’S FOR 
The new funds will go towards expanding the product in the U.K., India and U.S. markets. 
“After an incredible year of growth, RB is delighted to strengthen our partnership with Your.MD to deliver better self-care access and tools for consumers all over the world. We are excited to see the global expansion of the Healthily app, which will create immersive, digital-first experiences for consumers,” Arjun Purkayastha, senior vice president at RB, said in a statement. 
MARKET SNAPSHOT 
During the coronavirus there has been a renewed interest in chatbots and other tools to help patients figure out what level of care they should be seeking. Buoy Health, based in Boston Massachusetts, was one of the first chatbots to team up with epidemiologists to figure out how the virus was spreading.
Several health systems created their own symptom checkers specifically for the virus in order to help patients self-triage.
There are also several startups working on triage systems for a broad array of conditions. Polish company Infermedica scored $10.25 million in Series A funding in August, and AI-based virtual assistant GYANT raised $13.6 million in July.

Via Source link